Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPho) syndrome is a rare
autoinflammatory disorder disease characterized by skin lesions and osteoarticular …

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare
autoinflammatorydisorder without standardized therapy. IL-17 inhibitors have been effective …

SAPHO syndrome is a rare entity with skin and rheumatologic inflammatory presentation.
The treatment is not standardized, and in case of inadequate response to anti-inflammatory …

Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome is a rare disease
characterized by cutaneous and osteoarticular (OA) manifestations. Anti-TNF is the most …

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare
autoinflammatory disease with no standard treatment. Interleukin (IL)-6 inhibitors represent a …

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is an uncommon
autoinflammatory syndrome, with an estimated prevalence of 1 in 10,000 in the Caucasian …

Background The SAPHO syndrome is a relatively rare clinical entity characterized by a wide
range of dermatological and musculoskeletal manifestations. Biologics have been used in …

Summary SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome is a rare
disease with inflammatory osteoarticular and skin involvement. The pathogenesis of SAPHO …

Abstract Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome is a rare
autoinflammatory disease characterized by dermatological disorders and osteoarticular …

Synovitis‐acne‐pustulosis‐hyperostosis‐osteitis (SAPHO) syndrome is a rare disease with
an unknown entity that affects the skin and the peripheral and/or axial joints. Here, we report …